SOST and Myalgia: Additionally, patients undergoing glucocorticoid therapy for conditions such as rheumatoid arthritis, polymyalgia rheumatica and chronic inflammatory diseases exhibited a noteworthy decrease in sclerostin levels [14, 28, 29].